Avelumab
EMR 100070-005
Phase 3 small_molecule completed
Quick answer
Avelumab for First Line Non-Small Cell Lung Cancer is a Phase 3 program (small_molecule) at Serono Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Serono Europe Limited
- Indication
- First Line Non-Small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed